Kelly I. Griffey

In vivo pharmacological characterization of the structurally novel, potent, selective mGlu2/3 receptor agonist LY404039 in animal models of psychiatric disorders

Linda M. Rorick‐Kehn, Bryan G. Johnson, Karen M. Knitowski et al. · Psychopharmacology · 2007 · 157 citations

Medicine, Pharmacology, Psychiatry +8

Induction or protection of limbic seizures in mice by mGluR subtype selective agonists

Joseph P. Tizzano, Kelly I. Griffey, Darryle D. Schoepp · Neuropharmacology · 1995 · 138 citations

Life Sciences, Neuroscience, Pharmacology +10

The anxiolytic action of mGlu2/3 receptor agonist, LY354740, in the fear-potentiated startle model in rats is mechanistically distinct from diazepam

Joseph P. Tizzano, Kelly I. Griffey, Darryle D. Schoepp · Pharmacology Biochemistry and Behavior · 2002 · 74 citations

Medicine, Neuroscience, Pharmacology +15

Intracerebral 1S,3R-1-aminocyclopentane-1,3-dicarboxylic acid (1S,3R-ACPD) produces limbic seizures that are not blocked by ionotropic glutamate receptor antagonists

Joseph P. Tizzano, Kelly I. Griffey, J. A. Johnson et al. · Neuroscience Letters · 1993 · 51 citations

Life Sciences, Neuroscience, Pharmacology +13

(2<i>S</i>,1‘<i>S</i>,2‘<i>R</i>,3‘<i>R</i>)-2-(2‘-Carboxy-3‘-hydroxymethylcyclopropyl) Glycine Is a Highly Potent Group 2 and 3 Metabotropic Glutamate Receptor Agonist with Oral Activity

Iván Collado, Concepción Pedregal, Ana B. Bueno et al. · Journal of Medicinal Chemistry · 2003 · 37 citations · Full text

Medicine, Neuroscience, Pharmacology +13